These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18358605)

  • 1. Cleavage of normal and pathological forms of alpha-synuclein by neurosin in vitro.
    Kasai T; Tokuda T; Yamaguchi N; Watanabe Y; Kametani F; Nakagawa M; Mizuno T
    Neurosci Lett; 2008 May; 436(1):52-6. PubMed ID: 18358605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies.
    Iwata A; Maruyama M; Akagi T; Hashikawa T; Kanazawa I; Tsuji S; Nukina N
    Hum Mol Genet; 2003 Oct; 12(20):2625-35. PubMed ID: 12928483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational properties of the SDS-bound state of alpha-synuclein probed by limited proteolysis: unexpected rigidity of the acidic C-terminal tail.
    de Laureto PP; Tosatto L; Frare E; Marin O; Uversky VN; Fontana A
    Biochemistry; 2006 Sep; 45(38):11523-31. PubMed ID: 16981712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular neurosin degrades α-synuclein in cultured cells.
    Tatebe H; Watanabe Y; Kasai T; Mizuno T; Nakagawa M; Tanaka M; Tokuda T
    Neurosci Res; 2010 Aug; 67(4):341-6. PubMed ID: 20403393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calpain-resistant fragment(s) of alpha-synuclein regulates the synuclein-cleaving activity of 20S proteasome.
    Kim HJ; Lee D; Lee CH; Chung KC; Kim J; Paik SR
    Arch Biochem Biophys; 2006 Nov; 455(1):40-7. PubMed ID: 17005155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.
    Di Pasquale E; Fantini J; Chahinian H; Maresca M; Taïeb N; Yahi N
    J Mol Biol; 2010 Mar; 397(1):202-18. PubMed ID: 20114052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular insights into the interaction between alpha-synuclein and docosahexaenoic acid.
    De Franceschi G; Frare E; Bubacco L; Mammi S; Fontana A; de Laureto PP
    J Mol Biol; 2009 Nov; 394(1):94-107. PubMed ID: 19747490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentivirus mediated delivery of neurosin promotes clearance of wild-type α-synuclein and reduces the pathology in an α-synuclein model of LBD.
    Spencer B; Michael S; Shen J; Kosberg K; Rockenstein E; Patrick C; Adame A; Masliah E
    Mol Ther; 2013 Jan; 21(1):31-41. PubMed ID: 22508489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein.
    Mishizen-Eberz AJ; Norris EH; Giasson BI; Hodara R; Ischiropoulos H; Lee VM; Trojanowski JQ; Lynch DR
    Biochemistry; 2005 May; 44(21):7818-29. PubMed ID: 15909996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The conformation and the aggregation kinetics of α-synuclein depend on the proline residues in its C-terminal region.
    Meuvis J; Gerard M; Desender L; Baekelandt V; Engelborghs Y
    Biochemistry; 2010 Nov; 49(43):9345-52. PubMed ID: 20828147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy.
    Spencer B; Valera E; Rockenstein E; Trejo-Morales M; Adame A; Masliah E
    Mol Neurodegener; 2015 Sep; 10():48. PubMed ID: 26394760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies.
    Oueslati A; Fournier M; Lashuel HA
    Prog Brain Res; 2010; 183():115-45. PubMed ID: 20696318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro.
    Hoyer W; Cherny D; Subramaniam V; Jovin TM
    Biochemistry; 2004 Dec; 43(51):16233-42. PubMed ID: 15610017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceleration of alpha-synuclein aggregation by homologous peptides.
    Du HN; Li HT; Zhang F; Lin XJ; Shi JH; Shi YH; Ji LN; Hu J; Lin DH; Hu HY
    FEBS Lett; 2006 Jun; 580(15):3657-64. PubMed ID: 16764865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isomers of human alpha-synuclein stabilized by disulfide bonds exhibit distinct structural and aggregative properties.
    Jiang C; Chang JY
    Biochemistry; 2007 Jan; 46(2):602-9. PubMed ID: 17209570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat-mediated enrichment of α-synuclein from cells and tissue for assessing post-translational modifications.
    Vicente Miranda H; Xiang W; de Oliveira RM; Simões T; Pimentel J; Klucken J; Penque D; Outeiro TF
    J Neurochem; 2013 Sep; 126(5):673-84. PubMed ID: 23534813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiapoptotic property of human alpha-synuclein in neuronal cell lines is associated with the inhibition of caspase-3 but not caspase-9 activity.
    Li W; Lee MK
    J Neurochem; 2005 Jun; 93(6):1542-50. PubMed ID: 15935070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein.
    Marxreiter F; Nuber S; Kandasamy M; Klucken J; Aigner R; Burgmayer R; Couillard-Despres S; Riess O; Winkler J; Winner B
    Eur J Neurosci; 2009 Mar; 29(5):879-90. PubMed ID: 19291219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers.
    Beyer K
    Acta Neuropathol; 2006 Sep; 112(3):237-51. PubMed ID: 16845533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-triggered membrane interaction of the alpha-synuclein acidic tail.
    Tamamizu-Kato S; Kosaraju MG; Kato H; Raussens V; Ruysschaert JM; Narayanaswami V
    Biochemistry; 2006 Sep; 45(36):10947-56. PubMed ID: 16953580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.